Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 March 2026: Clinical Research  

Social Attitudes Towards Public Health Interventions in Community Pharmacies in Poland: A Nationwide Cross-Sectional Survey

Iwona Wrześniewska-Wal ORCID logo ABCDEF 1*, Kuba Sękowski ORCID logo BCEF 1, Andrzej Silczuk ORCID logo ADEF 2, Mateusz Jankowski ORCID logo ABCDE 1, Magdalena Waszyk-Nowaczyk ORCID logo AEF 3, Justyna Grudziąż-Sękowska ORCID logo CDEF 1

DOI: 10.12659/MSM.951732

Med Sci Monit 2026; 32:e951732

0 Comments

Abstract

0:00

BACKGROUND: Tobacco use and obesity are major modifiable risk factors for non-communicable diseases. Community pharmacists can support preventive health through education, counseling, and adherence monitoring. To assess public attitudes towards pharmacy-based public health interventions in Poland and identify factors influencing willingness to use these services: smoking cessation support, brief lifestyle advice, brief vaccination-related advice, and support for adherence to lifestyle recommendations from physicians.

MATERIAL AND METHODS: A nationwide cross-sectional survey was conducted among 1102 adults, representative of the population in terms of age, sex, and place of residence. Attitudes towards 5 pharmacy-based interventions were assessed using a structured, self-administered questionnaire designed to minimize social desirability bias. Multivariable logistic regression was used to identify determinants of service acceptance.

RESULTS: The highest acceptance was observed for support for adherence to physician lifestyle recommendations (74.3%), vaccination advice (66.8%), and basic health measurements (57.7%). Lower acceptance was found for lifestyle counseling (40.9%) and smoking cessation support (53.1%), with 32.0% uncertain regarding the latter. Positive attitudes were associated with household economic status (good: aOR 1.85, 95% CI 1.27-2.69; moderate: aOR 1.59, 95% CI 1.07-2.33), living in households with ≥3 members (aOR 1.75-1.83), active employment (aOR 1.62, 95% CI 1.18-2.22), chronic disease (aOR 1.36-1.49), male gender (aOR 1.72, 95% CI 1.32-2.23), and e-cigarette/heated tobacco use (aOR 1.78-2.52). No sociodemographic factors predicted acceptance of basic health measures.

CONCLUSIONS: Polish adults are generally receptive to pharmacy-based preventive services, particularly in support of adherence and vaccination counseling. The lower acceptance of lifestyle counseling and smoking cessation highlights the need for targeted education and integration of pharmacists into preventive care pathways.

Keywords: Cross-Sectional Studies, Pharmacy, Public Health, Smoking Cessation, Vaccination

Introduction

Tobacco smoking remains one of the leading preventable causes of death worldwide, responsible for over 8 million deaths annually and affecting 1.25 billion tobacco users [1]. Furthermore, it is estimated that by 2030, over 1 billion people will be living with obesity (BMI ≥30 kg/m2), which is a significant risk factor for many chronic diseases [2]. These examples of lifestyle-related diseases constitute a serious public health problem both globally and in Poland [3]. The Global Burden of Disease 2023 analysis for Poland indicates that the main source of years of life lost is lifestyle-related non-communicable diseases, primarily cardiovascular diseases, cancer, and type 2 diabetes [4]. Between 1990 and 2017, a significant decrease in the number of premature deaths due to non-communicable diseases was observed in Poland (by approximately 31.7%). However, many people still live with chronic conditions that limit their daily functioning, highlighting the long-term nature of these diseases [5]. These data underscore that prevention and early interventions, including lifestyle modification (diet, physical activity, smoking cessation, and reduced alcohol consumption), should be key elements of health policy.

In this context, pharmacists can play a crucial role by supporting patients with health education, health monitoring, and promoting healthy behaviors. Although pharmacists in Poland are traditionally classified as a medical profession responsible for drug delivery, pharmaceutical advice, and ensuring pharmacovigilance [6], the role of community pharmacies has expanded significantly in recent years. For example, during the COVID-19 pandemic, pharmacists were granted the authority to certify and administer vaccinations, a significant step towards the development of public health services in pharmacies [7].

Legislative changes were introduced in parallel. The Pharmacist Profession Act (2020) [8] introduced the concept of pharmaceutical care, creating a legal framework for the provision of additional services in pharmacies and enabling pharmacists to expand their scope of activities beyond traditional drug-related activities. Currently, public debate in Poland considers the expansion of pharmaceutical care, including the introduction of preventive health interventions in pharmacies (eg, blood pressure measurements, medication reviews, counseling on chronic disease prevention). However, there are no detailed regulations governing the financing and scope of these services in pharmacies. Only vaccinations available in pharmacies are financed by the public payer, the National Health Fund (NFZ), but the scope of reimbursement vary depending on the patient group (eg, age, pre-existing chronic diseases). As of August 25, 2025, 11 vaccinations, financed in whole or in part by public funds (including influenza, pneumococcal, and shingles), are available in Polish pharmacies that have signed agreements with the public payer [9].

In Poland, public authorities are increasingly considering the implementation of healthcare services in pharmacies as part of their preventive and health promotion policies. Polish pharmacists are also increasingly well-prepared to provide healthcare services in pharmacies, including blood pressure and glucose measurements, cardiovascular risk assessments, and brief advice on healthy lifestyles. In addition to professional development training, this preparation includes, among others, guidelines of the Polish Pharmaceutical Society and the Supreme Chamber of Pharmacists regarding standards for performing measurements [10] and conducting pharmaceutical consultations [11]. At the same time, pilot projects are being implemented, such as “Blood pressure measurement service and basic diagnostic screening tests (point-of-care) in a public pharmacy”, implemented in partner pharmacies by the Medical Center of the Cardinal Stefan Wyszyński University in Warsaw (CM UKSW), which aim to assess the effectiveness and safety of such interventions [12]. Furthermore, case law, including the judgment of the Supreme Administrative Court of 11 January 2012 (ref. II GSK 1365/10) [13], confirms that a public pharmacy may have a blood pressure monitor and perform free blood pressure measurements in the interest of public health, creating a formal basis for implementing similar services. Particular attention is being paid to the provision of smoking cessation counseling services in pharmacies, which, according to research, can effectively increase the percentage of people who quit smoking and reduce the risk of chronic diseases. The effectiveness of these efforts is confirmed by, among others, randomized controlled trials that have verified urinary cotinine concentrations 6 months after quitting smoking [14]. The public increasingly perceives pharmacists as specialists to whom one can turn for assistance with nicotine addiction therapy and available treatment options [15]. These observations suggest that pharmacies can play a vital role in chronic disease prevention and health promotion, extending beyond their traditional role in drug distribution. However, data on public attitudes towards public health interventions implemented in pharmacies remains lacking, highlighting the need for further research in this area.

This study aimed to assess public attitudes towards public health interventions in community pharmacies in Poland and to identify sociodemographic factors associated with willingness to use such services. Specifically, the study focused on 4 types of pharmacy-based interventions: smoking cessation support, brief healthy lifestyle advice, brief vaccination-related advice, and support for adherence to physician lifestyle recommendations.

Material and Methods

MEASURES:

The study questionnaire comprised questions assessing public attitudes towards public health interventions provided in community pharmacies, including basic health measurements, smoking cessation support, healthy lifestyle advice, preventive care advice (particularly regarding vaccinations), and support for adherence to medical lifestyle recommendations.

The questions were prepared based on a literature review. The questionnaire used a 5-point Likert scale with possible answers of “definitely yes”, “rather yes”, “rather no”, “definitely no” and “hard to say/not sure”. To facilitate the analysis, the responses of “definitely yes” and “rather yes” were combined [23].

In addition, all participants provided information on their age, gender, educational level, marital status, place of residence, household size, number of children, occupational status, self-reported household economic status, presence of chronic diseases, regular medication use, and smoking status.

The questionnaire was designed as a descriptive and exploratory tool, consisting of conceptually independent items assessing attitudes towards specific pharmaceutical services and public health interventions. Therefore, it did not form a unified scale, and calculation of Cronbach’s alpha was not appropriate or statistically justified.

A pilot test–retest study was conducted with 8 adults (aged 18–68 years). Participants completed the questionnaire twice, 5 days apart, to assess test–retest stability at the item level. The pilot study was conducted for methodological purposes only, and pilot data were not included in the main analysis, which was performed on an independent sample. Based on the pilot findings, 2 items were revised to improve clarity.

OPERATIONAL DEFINITIONS:

The presence of chronic diseases was defined as self-reported diagnosis of at least 1 chronic condition. Regular medication use was defined as taking any prescribed medications on a continuous basis for chronic conditions. Smoking status was categorized into 3 groups: conventional cigarette smoking, use of e-cigarettes or heated tobacco products, and non-smoking.

STATISTICAL ANALYSIS:

The survey results, presented as categorical variables, are displayed in tables using response counts and proportions. The chi-square test of independence was used to assess associations between participants’ sociodemographic characteristics and questionnaire responses.

Sociodemographic factors associated with the odds of a given response were examined using logistic regression analyses. Univariable logistic regression analyses were used as an initial exploratory step to identify candidate variables for inclusion in multivariable models [24]. The assumptions of the logistic regression models were verified, including assessment of multicollinearity and evaluation of model goodness-of-fit. The results of logistic regression analyses are expressed as odds ratios (ORs) with 95% confidence intervals (95% CIs) and corresponding P values. Although a conventional threshold of P<0.05 was applied, statistical significance was not interpreted as the sole criterion for relevance. IBM SPSS Statistics version 29 was used for all analyses. Because the study used a non-probability purposive/quota sampling approach, inferential statistics (including P values) should be interpreted with caution and are presented primarily as exploratory indicators of associations within the study sample.

This study used non-random, quota-based sampling; therefore, all reported statistical associations (chi-square tests, logistic regression analyses) are specific to the study sample, should be interpreted accordingly, and should not be generalized beyond the participants included in this research.

Results

CHARACTERISTICS OF THE STUDY POPULATION:

The survey included 1102 adult participants, mean age 48.2±15.9 years. Of this group, 604 (54.7%) were female and 498 (45.3%) were male. The largest proportion of participants was aged 60 years and older (29.4%). Over half of the respondents reported being married (51.1%) and raising children (62.0%). The majority of participants were professionally active (63.5%) and rated their household economic situation as good (48.6%) or moderate (38.0%), while 13.3% reported having a bad economic situation.

Regarding health status, more than half of the participants (55.6%) reported having chronic conditions, and 45.6% indicated regular use of medications, while 54.4% did not follow a continuous pharmacotherapy regimen. Analysis of tobacco use habits showed that 231 (20.9%) participants smoked conventional cigarettes, 84 (7.6%) used e-cigarettes or heated tobacco products, and the majority, and 787 (71.5%), reported not smoking. Detailed distributions of sociodemographic and clinical characteristics are presented in Table 1.

PUBLIC ATTITUDES TOWARDS PUBLIC HEALTH INTERVENTIONS IN COMMUNITY PHARMACIES:

The study revealed predominantly positive attitudes towards public health interventions offered in community pharmacies. The most highly accepted service was support for adherence to physician lifestyle recommendations, with 818 participants (74.3%) answering “definitely yes” or “rather yes”. High levels of acceptance were also recorded for receiving brief advice on preventive measures, particularly vaccinations (66.8%), as well as basic health measurements performed by a pharmacist (57.7%). The lowest acceptance rates were observed for lifestyle counseling services (40.9% positive responses, n=451) and smoking cessation support (53.1% positive responses, n=585). A notable proportion of “hard to say/not sure” responses (32.0%, n=353) was observed for smoking cessation services. The detailed distributions of support for various public health interventions are presented in Table 2.

FACTORS ASSOCIATED WITH PUBLIC ATTITUDES TOWARDS DIFFERENT PUBLIC HEALTH INTERVENTIONS:

The multivariable logistic regression analyses revealed distinct patterns of sociodemographic and health-related factors influencing public attitudes towards various public health interventions offered in community pharmacies among Polish adults.

There were no sociodemographic factors associated with the willingness to have basic health measures in community pharmacy among adults in Poland (Table 3).

Good (aOR: 1.85; 95% CI: 1.27–2.69; P=0.001) or moderate (aOR: 1.59; 95% CI: 1.07–2.33; P=0.02) household economic status and using e-cigarettes or heated tobacco products (aOR: 1.78; 95% CI: 1.11–2.87; P=0.02) were significantly associated with public support for smoking cessation services provided in community pharmacy among adults in Poland (Table 4).

Living in a household with at least 3 household members (aOR: 1.83; 95% CI: 1.25–2.70; P =0.002), active occupational status (aOR: 1.62; 95% CI: 1.18–2.22; P=0.003), moderate household economic status (aOR: 1.59; 95% CI: 1.06–2.39; P=0.03), and having chronic diseases (aOR: 1.49; 95% CI: 1.15–1.93; P=0.003) were significantly associated with willingness to receive brief advice on healthy lifestyle provided in community pharmacy (Table 5).

Male gender (aOR: 1.72; 95% CI: 1.32–2.23; P<0.001), having chronic diseases (aOR: 1.36; 95% CI: 1.05–1.75; P =0.02), and using e-cigarettes or heated tobacco products (aOR: 2.14; 95% CI: 1.21–3.79; P =0.01) were significantly associated with willingness to receive brief advice on preventive vaccinations provided in community pharmacy (Table 6).

Living in a household with at least 3 household members (aOR: 1.75; 95% CI: 1.18–2.63; P=0.006), having chronic diseases (aOR: 1.38; 95% CI: 1.04–1.84; P=0.03), and using e-cigarettes or heated tobacco products (aOR: 2.52; 95% CI: 1.30–4.88; P=0.006) were significantly associated with willingness to use services supporting adherence to medical recommendations on lifestyle provided in community pharmacies (Table 7). The multivariable logistic regression analyses for all sociodemographic and health-related factors are presented in Tables 3–7.

Discussion

PRACTICAL IMPLICATIONS:

Our results suggest that the future expansion of pharmacy-based health services should be grounded in a model of complementarity with existing physician care. Strengthening interprofessional collaboration will enable better utilization of healthcare resources, reduce waiting times for basic services, and improve access to preventive counseling. The gradual implementation of lifestyle counseling and smoking cessation programs will require additional educational efforts directed at patients and pharmacists to enhance trust and understanding of the role of community pharmacies in public health disease prevention.

STUDY LIMITATIONS:

This study has several important limitations. First, its cross-sectional design precludes the determination of causal relationships between individual characteristics and attitudes towards public health services in community pharmacies. Second, data were based on participants’ self-reported willingness to use services rather than their actual utilization. Third, the study did not assess the long-term effects of pharmaceutical interventions, limiting the evaluation of their sustained effectiveness. Fourth, the use of self-prepared questionnaires may have introduced systematic biases that could affect the validity of our findings. There was no full validation of the study questionnaire, only a pilot study. In particular, social desirability bias may have led participants to overstate their willingness to use pharmacy-based preventive services. While measures were taken to minimize this effect, its influence on the results cannot be entirely ruled out. Additionally, the online survey format may have excluded certain population segments with limited internet access or digital literacy, potentially affecting the representativeness of our sample despite quota sampling procedures. The sample cannot be considered representative of the entire population, as the CAWI method was used (approximately 5% of households in Poland do not have an internet access).

All statistical associations reported in this study are specific to the analyzed sample. Due to the use of non-probability quota sampling, P values and regression results cannot be generalized to the broader population. Inferential statistics are presented solely to explore patterns and associations within the study sample, which was structurally matched to the population in terms of gender, age, and place of residence.

This study focused on potential new health services in pharmacies, so general population was selected as a target population. Further studies should be carried out in other groups of respondents, such as those with chronic diseases or smokers.

Conclusions

The highest levels of patient acceptance were observed for pharmacist services that directly support medical recommendations, such as monitoring adherence to lifestyle advice and providing brief vaccination counseling. This indicates that patients prefer complementary rather than substitutive interventions in relation to physician-led care. Health-related factors, including the presence of chronic diseases and the use of e-cigarettes or heated tobacco products, were more strongly associated with acceptance of services than with demographic characteristics. Household conditions, particularly living in families with at least 3 members, as well as active employment and stable economic status, also were significant predictors of positive attitudes. In contrast, services such as lifestyle counseling and smoking cessation support had lower levels of acceptance. These findings show that the development of pharmaceutical care in public health should be oriented towards educational and preventive services.

References

1. World Health Organization: WHO clinical treatment guideline for tobacco cessation in adults, 2024, Geneva, World Health Organization Available from: https://iris.who.int/bitstream/handle/10665/377825/9789240096431-eng.pdf

2. World Obesity Federation: World Obesity Atlas 2022, 2022, London, World Obesity Federation Available from: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2022

3. Global Burden of Disease Collaborative Network: Global Burden of Disease Study 2021 (GBD 2021) results, 2024, Seattle (WA), Institute for Health Metrics and Evaluation (IHME) Available from: https://vizhub.healthdata.org/gbd-results/

4. GBD 2023 Poland Collaborators, The burden of diseases, injuries, and risk factors by voivodship in Poland, 1990–2023: A systematic analysis for the Global Burden of Disease Study 2023: Lancet Reg Health Eur, 2025; 58; 101431

5. Gańczak M, Miazgowski T, Kożybska M, Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017: PLoS One, 2020; 15(3); e0226766

6. Żuk A, Machuca M, Pharmaceutical care services in community pharmacies: An umbrella review of global evidence with insights from Polish and Spanish practices: Integr Pharm Res Pract, 2025; 14; 113-36

7. Wrześniewska-Wal I, Grudziąż-Sękowska J, Pinkas J, Jankowski M, Public knowledge and beliefs regarding pharmacy-based immunization in Poland: A nationwide cross-sectional study: Vaccines (Basel), 2024; 12(8); 835

8.

9. Ministry of Health, Announcement regarding the list of vaccinations administered in pharmacies eligible for full or partial reimbursement by the National Health Fund: Off J Minist Health, 2025(54) Available from: https://dziennikmz.mz.gov.pl/DUM_MZ/2025/54/oryginal/akt.pdf

10. Polish Chamber of Pharmacists; Polish Pharmaceutical Society; Centre for Postgraduate Medical Education: Guidelines for pharmacists on performing basic anthropometric measurements and their use in assessing the patient’s nutritional status, 2024, Warsaw, CMKP Available from: https://www.mckp.uj.edu.pl/cm/uploads/2024/01/pomiary-antropometryczne-wytyczne-dla-farmaceutow-fn-20231215.pdf

11. Team for Standardization of Pharmaceutical Care of the Polish Chamber of Pharmacists and the Polish Pharmaceutical Society: Recommendations for the management of patients covered by the pharmaceutical service “New Medicine.”, 2023, Warsaw, Polish Chamber of Pharmacists Available from: https://opiekafarmaceutyczna.nia.org.pl/wp-content/uploads/2023/01/Nowy-Lek-publikacja.pdf

12. : Service of blood pressure measurement and basic point-of-care screening tests in community pharmacies: research project, 2025, Warsaw, Cardinal Stefan Wyszyński University in Warsaw (UKSW) Available from: https://www.ptfarm.pl/towarzystwo/organizacja/sekcje/54/1914/2496

13. Supreme Administrative Court: Judgment of 11 January 2012, case no. II GSK 1365/10, Central Database of Administrative Court Decisions Available from: http://orzeczenia.nsa.gov.pl/cbo/query

14. Dent LA, Harris KJ, Noonan CW, Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation: Ann Pharmacother, 2009; 43(2); 194-201

15. Goniewicz ML, Lingas EO, Czogala J, Koszowski B, Zielinska-Danch W, Sobczak A, The role of pharmacists in smoking cessation in Poland: Eval Health Prof, 2010; 33(1); 81-95

16. Statistics Poland: Population in figures Available from: https://plwliczbach.stat.gov.pl/EN/population.html

17. Silczuk A, Lewandowska A, Baran T, Sociocultural correlates and epidemiological patterns of non-alcoholic beer consumption: A cross-sectional study in Poland: BMJ Open, 2025; 15(7); e100408

18. Lewandowska A, Silczuk A, Mularczyk-Tomczewska P, Awareness of mental disorders and their risk factors – A nationwide cross-sectional survey among adults in Poland: Front Psychiatry, 2025; 16; 1599683

19. Mularczyk-Tomczewska P, Lewandowska A, Kamińska A, Patterns of energy drink use, risk perception, and regulatory attitudes in the adult Polish lopulation: Results of a cross-sectional survey: Nutrients, 2025; 17(9); 1458

20. : Ariadna Research Panel Available from: https://panelariadna.com/

21. Jankowski M, Grudziąż-Sękowska J, Wrześniewska-Wal I, National HPV vaccination program in Poland: Public awareness, sources of knowledge, and willingness to vaccinate children against HPV: Vaccines (Basel), 2023; 11(8); 1371

22. Ethics Committee at the Centre of Postgraduate Medical Education: Resolution No. 71/2025, dated 16 July 2025, 2025, Warsaw, CMKP

23. Streiner DL, Norman GR, Cairney J: Health measurement scales: A practical guide to their development and use, 2015, Oxford, Oxford University Press

24. Hosmer DW, Lemeshow S, Sturdivant RX: Applied logistic regression, 2013, Hoboken (NJ), Wiley

25. Eades CE, Ferguson JS, O’Carroll RE, Public health in community pharmacy: A systematic review of pharmacist and consumer views: BMC Public Health, 2011; 11; 582

26. Verma RK, Chong WW, Taha NA, Paraidathathu T, A qualitative study exploring community pharmacists’ experiences and views about weight management interventions and services in Klang Valley, Malaysia: Front Public Health, 2021; 9; 720928

27. Alhomoud IS, Cook E, Patel D, Effect of pharmacist interventions on the management of overweight and obesity: A systematic review: J Am Pharm Assoc (2003), 2024; 64(3); 102058

28. Lee TA, King M, Young SW, Tsuyuki RT, Community pharmacy-based blood pressure screening in Newfoundland and Labrador, Canada for World Hypertension Day 2022: A cross-sectional study: CJC Open, 2023; 6(5); 728-34

29. Hijazi MA, Shatila H, El-Lakany A, Role of community pharmacists in weight management: Results of a national study in Lebanon: BMC Health Serv Res, 2020; 20; 386

30. Rohla M, Haberfeld H, Sinzinger H, Systematic screening for cardiovascular risk at pharmacies: Open Heart, 2016; 3; e000497

31. Prax K, Schmiedel K, Hepp T, Preventive care in type 2 diabetes: Results of a randomized, controlled trial in community pharmacies: Diabetes Care, 2021; 44(8); e157-e59

32. Hiscock R, Dobbie F, Bauld L, Smoking cessation and socioeconomic status: An update of existing evidence from a national evaluation of English Stop Smoking Services: Biomed Res Int, 2015; 2015; 274056

33. Brett K, Yeung SST, Ford C: Pharmacist-led interventions for tobacco smoking cessation: A review of clinical effectiveness and cost-effectiveness, 2019, Ottawa (ON), Canadian Agency for Drugs and Technologies in Health

34. Pisinger C, Toxværd CG, Rasmussen M, Smoking cessation programs are less effective in smokers with low socioeconomic status even when financial incentives for quitting smoking are offered: A community-randomized smoking cessation trial in Denmark: Int J Environ Res Public Health, 2022; 19; 17-10879

35. Spoelstra SK, van de Graaf RC, Dijkstra A, Residential treatment exclusively for tobacco use disorder: A narrative review: J Addict Med, 2024; 18(1); 33-41

36. Bouchet-Benezech B, Champanet B, Rouzaud P, Smoking cessation at the pharmacy: Feasibility and benefits based on a French observational study with six-month follow-up: Subst Abuse Rehabil, 2018; 9; 31-42

37. World Health Organization: WHO FCTC implementation database: Czechia – Progress made in implementing Article 14, 2020, Geneva (CH), World Health Organization Available from: https://extranet.who.int/fctcapps/fctcapps/fctc/implementation-database/indicators/progress-made-implementing-article-14

38. Supreme Pharmaceutical Chamber: Report – pilot implementation of pharmaceutical care with the practices of the opieka.farm group, 2020, Warsaw (PL), Supreme Pharmaceutical Chamber Available from: [in Polish]https://www.nia.org.pl/wp-content/uploads/2021/04/RAPORT_OPIEKA_FARMACEUTYCZNA.pdf

39. , Council of Ministers Regulation of 30 March 2021 on the National Health Program for 2021–2025: Journal of Laws, 2021; 642

40. Kasza KA, Rivard C, Goniewicz ML, Characteristics of electronic cigarettes and smoking cessation among adult users: JAMA Netw Open, 2024; 7(8); e2423960

41. Lancaster T, Stead LF, Individual behavioural counselling for smoking cessation: Cochrane Database Syst Rev, 2017; 3; CD001292

42. Tran MT, Holdford DA, Kennedy DT, Small RE, Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice: Pharmacotherapy, 2002; 22(12); 1623-31

43. Steed L, Sohanpal R, Todd A, Community pharmacy interventions for health promotion: Effects on professional practice and health outcomes: Cochrane Database Syst Rev, 2019; 12; CD011207

44. Eickhoff C, Schulz M, Pharmaceutical care in community pharmacies: Practice and research in Germany: Ann Pharmacother, 2006; 40(4); 729-35

45. International Pharmaceutical Federation (FIP): Beating non-communicable diseases in the community: the contribution of pharmacists, 2019, The Hague (NL), FIP Available from: https://www.fip.org/files/content/publications/2019/beating-ncds-in-the-community-the-contribution-of-pharmacists.pdf

46. Soodi O, Hesari E, Hojjatifard R, Seyedifar M, Consumers’ willingness to pay for pharmacist counselling services and the factors affecting it in community pharmacies: Iran J Pharm Res, 2023; 22(1); e132736

47. Peletidi A, Petrides M, Birlirakis V, Advanced clinical services in community pharmacies: Training challenges and real-world applications, with a focus on Greek-speaking countries: J Pharm Policy Pract, 2025; 18; 2455066

48. Raczkiewicz D, Owoc J, Bojar I, Sarecka-Hujar B, Satisfaction of people at post-working age with pharmacists’ health promotion in Poland: BMC Public Health, 2024; 24; 281

49. World Health Organization: WHO report on the global tobacco epidemic 2021: Addressing new and emerging products, 2021, Geneva (CH), WHO Available from: https://www.who.int/publications/i/item/9789240032095

50. Maidment I, Young E, MacPhee M, Rapid realist review of the role of community pharmacy in the public health response to COVID-19: BMJ Open, 2021; 11; e050043

51. Manfrin A, Tinelli M, Thomas T, Krska J, A cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients: BMC Health Serv Res, 2017; 17; 300

52. Ali ZZ, Skouteris H, Pirotta S, Interventions to expand community pharmacists’ scope of practice: Pharmacy (Basel), 2024; 12(3); 95

53. Lapointe-Shaw L, Bell CM, Austin PC, Community pharmacy medication review, death, and re-admission after hospital discharge: A propensity score-matched cohort study: BMJ Qual Saf, 2020; 29; 41-51

54. Elliott RA, Boyd MJ, Salema NE, Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service: BMJ Qual Saf, 2016; 25; 747-58

55. Pacini M, Smith RD, Wilson EC, Holland R, Home-based medication review in older people: Is it cost-effective?: Pharmacoeconomics, 2007; 25; 171-80

56. Wrześniewska-Wal I, Pinkas J, Ostrowski J, Jankowski M, Pharmacists’ perceptions of physician–pharmacist collaboration: A 2022 cross-sectional survey in Poland: Healthcare (Basel), 2023; 11(17); 2444

57. Lewicki J, Religioni U, Merks P, Evaluation of the community pharmacy comorbidities screening service on patients with chronic diseases: Patient Prefer Adherence Jul 17, 2021; 15; 1611-19

58. Presley B, Groot W, Pavlova M, Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis: Res Social Adm Pharm, 2019; 15(9); 1057-67

59. Pousinho S, Morgado M, Falcão A, Alves G, Pharmacist interventions in the management of type 2 diabetes mellitus: A systematic review of randomized controlled trials: J Manag Care Spec Pharm, 2016; 22(5); 493-515

60. Merks P, Cameron JD, Balcerzak M, Evaluation of a pharmacist-led intervention to improve medication adherence in patients initiating dabigatran treatment: A comparison with standard pharmacy practice in Poland: BMC Prim Care, 2022; 23; 210

61. Farsalinos KE, Barbouni A, Association between electronic cigarette use and smoking cessation in the European Union in 2017: Analysis of a representative sample of 13 057 Europeans from 28 countries: Tob Control, 2021; 30(1); 71-76

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750